1. Meier, FM, Frommer, KW, Dinser, R, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012; 71(8): 1355–1360.
Google Scholar | Crossref | Medline2. Varga, J, Trojanowska, M, Kuwana, M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord 2017; 2(3): 137–152.
Google Scholar | SAGE Journals3. Scher, JU, Abramson, SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 2011; 7: 569–578.
Google Scholar | Crossref | Medline4. Baraut, J, Michel, L, Verrecchia, F, et al. Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 2010; 10(2): 65–73.
Google Scholar | Crossref | Medline5. Sakkas, LI, Platsoucas, CD. Is systemic sclerosis an antigen-driven T cell disease? Arthritis Rheum 2004; 50(6): 1721–1733.
Google Scholar | Crossref | Medline6. Giovannetti, A, Rosato, E, Renzi, C, et al. Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes. Clin Immunol 2010; 137(1): 122–133.
Google Scholar | Crossref | Medline7. Harrington, LE, Hatton, RD, Mangan, PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6(11): 1123–1132.
Google Scholar | Crossref | Medline8. Park, H, Li, Z, Yang, XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6(11): 1133–1141.
Google Scholar | Crossref | Medline9. Radstake, TR, van Bon, L, Broen, J, et al. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS ONE 2009; 4: e5903.
Google Scholar | Crossref10. Rodríguez-Reyna, TS, Furuzawa-Carballeda, J, Cabiedes, J, et al. Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatol Int 2012; 32(9): 2653–2660.
Google Scholar | Crossref | Medline11. Truchetet, ME, Brembilla, NC, Montanari, E, et al. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 2011; 13(5): R166.
Google Scholar | Crossref | Medline12. Omenetti, S, Bussi, C, Metidji, A, et al. The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 cells. Immunity 2019; 51: 77.e6–89.e6.
Google Scholar | Crossref | Medline13. Miossec, P, Kolls, JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012; 11(10): 763–776.
Google Scholar | Crossref | Medline14. Tabarkiewicz, J, Pogoda, K, Karczmarczyk, A, et al. The role of IL-17 and Th17 lymphocytes in autoimmune diseases. Arch Immunol Ther Exp 2015; 63(6): 435–449.
Google Scholar | Crossref | Medline15. Chen, K, Kolls, JK. Interluekin-17A (IL17A). Gene 2017; 614: 8–14.
Google Scholar | Crossref | Medline16. Veldhoen, M. Interleukin 17 is a chief orchestrator of immunity. Nat Immunol 2017; 18: 612–621.
Google Scholar | Crossref | Medline17. Monin, L, Gaffen, SL. Interleukin 17 family cytokines: signaling mechanisms, biological activities, and therapeutic implications. Cold Spring Harb Perspect Biol 2018; 10: a028522.
Google Scholar | Crossref | Medline18. Brevi, A, Cogrossi, LL, Grazia, G, et al. Much more than IL-17A: cytokines of the IL-17 family between microbiota and cancer. Front Immunol 2020; 11: 565470.
Google Scholar | Crossref | Medline19. Cua, DJ, Tato, CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10(7): 479–489.
Google Scholar | Crossref | Medline20. McGeachy, MJ, Cua, DJ, Gaffen, SL. The IL-17 family of cytokines in health and disease. Immunity 2019; 50: 892–906.
Google Scholar | Crossref | Medline21. Gaffen, SL, Jain, R, Garg, AV, et al. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 2014; 14(9): 585–600.
Google Scholar | Crossref | Medline22. Mangan, PR, Su, LJ, Jenny, V, et al. Dual inhibition of interleukin-23 and interleukin-17 offers superior efficacy in mouse models of autoimmunity. J Pharmacol Exp Ther 2015; 354(2): 152–165.
Google Scholar | Crossref | Medline23. Patel, DD, Kuchroo, VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity 2015; 43: 1040–1051.
Google Scholar | Crossref | Medline24. Chizzolini, C, Dufour, AM, Brembilla, NC. Is there a role for IL-17 in the pathogenesis of systemic sclerosis? Immunol Lett 2018; 195: 61–67.
Google Scholar | Crossref | Medline25. Xing, X, Yang, J, Yang, X, et al. IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway. PLoS ONE 2013; 8(12): e85032.
Google Scholar | Crossref26. Fossiez, F, Djossou, O, Chomarat, P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183: 2593–2603.
Google Scholar | Crossref | Medline27. Kurasawa, K, Hirose, K, Sano, H, et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 2000; 43(11): 2455–2463.
Google Scholar | Crossref | Medline28. Gu, L, Xu, Q, Cao, H. 1,25(OH)2D3 protects liver fibrosis through decreasing the generation of TH17 cells. Med Sci Monit 2017; 23: 2049–2058.
Google Scholar | Crossref | Medline29. Wree, A, McGeough, MD, Inzaugarat, ME, et al. NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice. Hepatology 2018; 67(2): 736–749.
Google Scholar | Crossref | Medline30. Zepeda-Morales, AS, Del Toro-Arreola, S, García-Benavides, L, et al. Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-β2 expression. Ann Hepatol 2016; 15(3): 418–426.
Google Scholar | Crossref | Medline31. Meng, F, Wang, K, Aoyama, T, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012; 143(3): 765.e3–776.e3.
Google Scholar | Crossref | Medline32. Amara, S, Lopez, K, Banan, B, et al. Synergistic effect of pro-inflammatory TNFα and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis. Mol Immunol 2015; 64(1): 26–35.
Google Scholar | Crossref | Medline33. Tan, Z, Qian, X, Jiang, R, et al. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 2013; 191: 1835–1844.
Google Scholar | Crossref | Medline34. Chakir, J, Shannon, J, Molet, S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003; 111(6): 1293–1298.
Google Scholar | Crossref | Medline35. Jiang, G, Liu, CT, Zhang, WD. IL-17A and GDF15 are able to induce epithelial-mesenchymal transition of lung epithelial cells in response to cigarette smoke. Exp Ther Med 2018; 16(1): 12–20.
Google Scholar | Medline36. Wilson, MS, Madala, SK, Ramalingam, TR, et al. Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 2010; 207: 535–552.
Google Scholar | Crossref | Medline37. Zhou, X, Loomis-King, H, Gurczynski, SJ, et al. Bone marrow transplantation alters lung antigen-presenting cells to promote TH17 response and the development of pneumonitis and fibrosis following gammaherpesvirus infection. Mucosal Immunol 2016; 9(3): 610–620.
Google Scholar | Crossref | Medline38. Feng, W, Li, W, Liu, W, et al. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp Mol Pathol 2009; 87(3): 212–218.
Google Scholar | Crossref | Medline39. Liu, W, Wang, X, Feng, W, et al. Lentivirus mediated IL-17R blockade improves diastolic cardiac function in spontaneously hypertensive rats. Exp Mol Pathol 2011; 91(1): 362–367.
Google Scholar | Crossref | Medline40. Valente, AJ, Yoshida, T, Gardner, JD, et al. Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1. Cell Signal 2012; 24(2): 560–568.
Google Scholar | Crossref | Medline41. Liu, Y, Zhu, H, Su, Z, et al. IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway. Int Immunol 2012; 24(10): 605–612.
Google Scholar | Crossref | Medline42. Zhou, SF, Yuan, J, Liao, MY, et al. IL-17A promotes ventricular remodeling after myocardial infarction. J Mol Med 2014; 92(10): 1105–1116.
Google Scholar | Crossref | Medline43. Chang, SL, Hsiao, YW, Tsai, YN, et al. Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure. J Mol Cell Cardiol 2018; 122: 69–79.
Google Scholar | Crossref | Medline44. Faust, SM, Lu, G, Marini, BL, et al. Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol 2009; 183: 7297–7306.
Google Scholar | Crossref | Medline45. Needleman, BW, Wigley, FM, Stair, RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 1992; 35(1): 67–72.
Google Scholar | Crossref | Medline46. Scala, E, Pallotta, S, Frezzolini, A, et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004; 138(3): 540–546.
Google Scholar | Crossref | Medline47. Koch, AE, Kronfeld-Harrington, LB, Szekanecz, Z, et al. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology 1993; 61(5–6): 239–246.
Google Scholar | Crossref | Medline48. Yang, X, Yang, J, Xing, X, et al. Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction. Arthritis Res Ther 2014; 16: R4.
Google Scholar | Crossref49. Zhou, Y, Hou, W, Xu, K, et al. The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis. Hum Immunol 2015; 76(1): 22–29.
Google Scholar | Crossref | Medline50. Valentini, G, Della Rossa, A, Bombardieri, S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001; 60: 592–598.
Google Scholar | Crossref |